Publicacións en colaboración con investigadores/as de Complejo Asistencial de Ávila (20)

2022

  1. Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study

    Medicine (United States), Vol. 101, Núm. 24, pp. E29252

  2. Juntos Ante el Peligro: Resultados de traquetomías para pacientes críticos por COVID-19, unidades multicéntricas de ORL en Castilla y León: Estudio de cohortes de más de 139 pacientes críticos COVD-19

    Revista ORL, Vol. 13, Núm. 2, pp. 65-66

  3. Usefulness of the 5MPB-Toledo model to predict bacteremia in the elderly patient

    Infectio, Vol. 26, Núm. 2, pp. 128-136

2021

  1. Demographic, clinical, and functional determinants of antithrombotic treatment in patients with nonvalvular atrial fibrillation

    BMC Cardiovascular Disorders, Vol. 21, Núm. 1

  2. Effect of the type of specialized nutrition support on the course of the patient with amyotrophic lateral sclerosis (ALS). Interhospital registry SCLEDyN

    Endocrinologia, Diabetes y Nutricion, Vol. 68, Núm. 10, pp. 699-707

2020

  1. Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia

    European Journal of Haematology, Vol. 104, Núm. 3, pp. 259-270

2017

  1. Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice

    International Journal of Hematology, Vol. 106, Núm. 4, pp. 508-516

  2. Prognostic accuracy of SIRS criteria, qSOFA score and GYM score for 30-day-mortality in older non-severely dependent infected patients attended in the emergency department

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 12, pp. 2361-2369

2016

  1. Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice

    European Journal of Haematology, Vol. 97, Núm. 3, pp. 297-302

  2. Síndrome de Turner: análisis de 42 casos

    Medicina Clinica, Vol. 147, Núm. 8, pp. 348-351

2015

  1. Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia

    American Journal of Hematology, Vol. 90, Núm. 3, pp. E40-E43

2014

  1. Ambulatory surgery in orthopedics: Experience of over 10,000 patients

    Journal of Orthopaedic Science, Vol. 19, Núm. 2, pp. 332-338

  2. COL4A4 gene study of a european population: Description of new mutations causing autosomal dominant alport syndrome

    International Journal of Molecular Epidemiology and Genetics, Vol. 5, Núm. 4, pp. 177-184

  3. Funduscopic results after 4-year follow-up treatment with ranibizumab for age-related macular degeneration in a region of Spain

    BMC Ophthalmology, Vol. 14, Núm. 1

  4. Guideline on management of solitary pulmonary nodule

    Archivos de Bronconeumologia, Vol. 50, Núm. 7, pp. 285-293

2013

  1. La neurólisis del nervio mediano en el paciente anciano: Evaluación a largo plazo

    Revista Espanola de Geriatria y Gerontologia, Vol. 48, Núm. 2, pp. 65-68

  2. Long-term effects of preserving or splitting the carpal ligament in carpal tunnel operation

    Journal of Plastic Surgery and Hand Surgery, Vol. 47, Núm. 4, pp. 263-267

  3. Long-term results of the retrocapital metatarsal percutaneous osteotomy for hallux valgus

    International Orthopaedics, Vol. 37, Núm. 9, pp. 1799-1803

  4. Oxford phase 3 unicondylar knee arthroplasty through a minimally invasive approach: Long-term results

    International Orthopaedics, Vol. 37, Núm. 5, pp. 833-838

2012

  1. Latent tuberculosis seems not to reactivate in multiple sclerosis patients on natalizumab

    Journal of Neuroimmunology, Vol. 243, Núm. 1-2, pp. 103-105